Medication info

Rosuvastatin Calcium 10mg Tablets

Prescription medicationTabletExpired
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Kyungbang Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
28 tablets per box [14 tablets/PTP×2]
Approval status
Expired

MFDS item code 202000659 · Approved 2020.02.05

This product's status changed to Expired on 2025.02.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who uses it
Adults
Adult dosage
1. Primary hypercholesterolemia (type IIa), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this product and continue it throughout the treatment period. This product may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 2. Elderly patients : No dose adjustment is necessary. 3. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this product to patients with moderate renal impairment. 4. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this product to patients with active liver disease. 5. Race : Because systemic exposure to this product is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Ingredients

Manufacturer
Kyungbang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Hypercholesterolemia
  • dysbetalipoproteinemia
  • cardiovascular disease risk factors
  • stroke risk
  • myocardial infarction risk
  • risk of arterial revascularization
View approved original text

This medication is used as an adjunct when dietary changes and exercise alone are not sufficient for patients with primary hypercholesterolemia and mixed hyperlipidemia. It is also utilized as an adjunct to dietary therapy or other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. This medicine helps to lower total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, thereby slowing the progression of atherosclerosis. It is also used as an adjunct to dietary therapy for patients with primary dysbetalipoproteinemia. Furthermore, it is effective for reducing the risk of stroke, myocardial infarction, and arterial revascularization in men aged 50 years and older and women aged 60 years and older who have elevated high-sensitivity C-reactive protein levels and additional cardiovascular risk factors. This medication contributes to lowering the risk of hyperlipidemia and cardiovascular disease.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this product and continue it throughout the treatment period. This product may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 2. Elderly patients : No dose adjustment is necessary. 3. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this product to patients with moderate renal impairment. 4. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this product to patients with active liver disease. 5. Race : Because systemic exposure to this product is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Precautions

This medication should not be used in certain patients. It should not be administered to individuals with allergies to its components, severe liver dysfunction, muscle disorders, those taking certain immunosuppressants, severe renal impairment, pregnant or breastfeeding women, or fertile women not using proper contraception. In particular, high dose usage is prohibited in patients at high risk for muscle disorders. Patients with genetic metabolic disorders such as lactose intolerance should also avoid this medication. Since this medication can affect liver function, patients with a history of liver disease or those who consume alcohol excessively should undergo liver function tests before and during treatment. Muscle-related side effects such as myalgia, muscle weakness, and muscle damage may occur; if any of these symptoms arise, medical personnel should be notified immediately. Patients at high risk for muscle damage should check muscle enzyme levels before treatment and be monitored periodically during treatment. If severe muscle damage or rhabdomyolysis occurs, discontinuation of the medication is necessary, and re-administration will be determined based on symptoms. This medication may raise blood sugar levels in some patients, so those at risk for diabetes should take care to manage their blood glucose. Special caution is needed for the elderly, patients with reduced renal function, and those with hypothyroidism. Furthermore, this medication can interact with various drugs, so it is essential to consult with medical personnel if taking other medications. Pregnant or breastfeeding women should not use this medication, and women of childbearing potential should use appropriate contraception. In cases of overdose, as there is no specific antidote, immediate medical attention should be sought, and liver function and muscle enzyme levels should be monitored. This medication does not significantly impact driving or machine operation, but caution is advised as dizziness and similar symptoms may occur. Lastly, while serious side effects like severe skin reactions are rare, if symptoms such as rashes or swelling appear, discontinuation should occur immediately, and consultation with medical personnel is advised.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug-induced lichenoid rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, systemic pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air or moisture and is best kept at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

28 tablets per box [14 tablets/PTP×2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.